Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-02

Clinical Trial Update: Celgosivir as a Treatment Against Dengue [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating celgosivir for dengue fever has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celgosivir (celgosivir)

Snippet

Sponsor: Singapore General Hospital | Conditions: Dengue Fever | Phase 1, Phase 2 | Status: COMPLETED